Efficacy of Imatinib Mesylate in Hypereosinophilic Syndromes

Mise à jour : Il y a 4 ans
Référence : NCT00787384

Femme et Homme

  • | Pays :
  • Italy
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The study was performed to assess: 1) clinical activity of Imatinib in patients with HES, CEL and CIH; 2) correlation between Imatinib activity and specific disease subtype; 3) long-term outcome of HES, CEL and CIH patients treated with Imatinib; 4) safety and tolerability of Imatinib administration.


Critère d'inclusion

  • Hypereosinophilic Syndrome ,Chronic Eosinophilic Leukemia ,Chronic Idiopathic Hypereosinophilia

Liens